AZ funded Non clinical PhD Studentship (Fixed Term)

University of Cambridge
Cambridge
7 months ago
Applications closed

Applications are invited for a 4-year PhD studentship based in the Department Pharmacology /Cambridge Stem Cell Institute (CSCI), University of Cambridge and the new AstraZeneca Discovery Centre at Cambridge. The student will be working on a collaborative project jointly supervised by Prof Walid Khaled in Pharmacology/CSCI, Dr Mark Albertella and Dr Andrew Reynolds at AstraZeneca.

The project, entitled "Therapeutic cancer prevention of hereditary cancers"' aims to test various therapeutic options to prevent the development of breast cancer in high-risk individuals. More details can be found in the attachments.

CandidateWe are looking for a highly motivated and enthusiastic individual capable of thinking and working independently. This position offers the unique opportunity to engage with a multidisciplinary team, including computational biologists and experimentalist from University of Cambridge and AstraZeneca. Prior experience with mouse model and/or single cell genomics is welcome.

Applicants should have, or shortly expect to obtain, a first or upper second-class degree from a UK university, or an equivalent standard from an overseas university, in a relevant subject such as cell or developmental biology, or biochemistry. These positions are open to UK citizens or overseas students who meet the UK residency requirements (home fees) or can augment the funds to cover the extra costs associated with international student fees through scholarships or funding schemes. Students will not be allowed to supplement fees via self-funding. Full details of the University's entrance requirements and scholarships are specified on the following link: .

FundingFull funding covering Maintenance fees at £21,500 per annum and the University Composition Fee is provided for the studentship, with effect from 1 October 2025.

PhD in Pharmacology (Full-time)
Start Date: 1st October 2025
Project Supervisor: Walid T. Khaled
Project Title: AZ funded non-clinical PhD Studentship (Fixed Term) in "Therapeutic cancer prevention of hereditary cancers"
Research Proposal: Please add the project abstract listed above

Applications should include:

Two academic references Transcript CV/resume Evidence of competence in English (If required - you can check using our tool) Statement of Interest outlining your suitability, why you are interested in a PhD in this area, your background and research interests. School of Biological Sciences - Widening Participation Questionnaire (applicants are asked to complete an additional form to provide contextual information about their previous study. Find out more about our use of contextual information here: .

Completed applications (with ALL supporting documentation and references) to be submitted via the portal by 23:59pm (midnight) UK time on Mon 11th November 2024 at the latest. Interviews will be scheduled for the end of November and early December.

The University actively supports equality, diversity and inclusion and encourages applications from all sections of society. We place major emphasis on the importance of teamwork and an enjoyable work environment as a foundation for performing internationally leading research. This will allow the student to acquire cutting edge research methodologies in a supportive environment, where they can focus on making the best possible scientific progress.

The University has a responsibility to ensure that all employees are eligible to live and work in the UK.

Get the latest insights and jobs direct. Sign up for our newsletter.

By subscribing you agree to our privacy policy and terms of service.

Industry Insights

Discover insightful articles, industry insights, expert tips, and curated resources.

Rural-Remote Biotech Jobs: Making Waves Beyond the Big Cities

A Fresh Outlook for Biotech Professionals When people think of biotech jobs in the UK, their minds often jump to the famous “Golden Triangle” encompassing London, Oxford, and Cambridge—areas historically rich in research institutes, biotech start-ups, and Big Pharma headquarters. While these regions remain crucial to the sector, the landscape is evolving. New technologies, changes in work culture, and the increasing feasibility of remote and hybrid roles are drawing life science professionals away from city centres and into the rural or coastal parts of the country. At BiotechnologyJobs.co.uk, we see more and more postings for roles in beautiful, often overlooked areas—from the hills of North Wales and the rolling landscapes of Yorkshire to the spectacular coastlines of Cornwall and Argyll. Even jobseekers are becoming more adventurous with their search terms, going beyond “lab technician in London” to include lifestyle-driven queries like “tech jobs by the sea” or “biotech remote countryside.” Why are these opportunities emerging now? The COVID-19 pandemic changed perceptions around how research and product development teams operate. Laboratories once thought it essential for everyone to be physically present all the time, but many tasks—particularly in data-intensive or administrative areas—proved workable with remote collaboration. Moreover, biotech itself is diversifying. Marine biology initiatives, agricultural biotech, digital health, and bioinformatics often take place outside city labs, tapping into local ecosystems or farmland as living laboratories. Below, we delve into how biotech professionals can embrace rural or seaside living without sacrificing career momentum. Whether you’re a research scientist hoping to reduce your urban commute, a bioinformatician who can work from anywhere, or a regulatory affairs specialist longing to live near the coast, rural-remote biotech roles offer exciting, career-enhancing possibilities.

Quantum-Enhanced AI in Biotech: The Next Big Leap for Life Sciences

Biotechnology sits at the confluence of science and innovation, pushing the boundaries of what’s possible in healthcare, agriculture, and beyond. In the past few decades, Artificial Intelligence (AI) has supercharged this field by offering predictive modelling and data analysis tools that are faster and more accurate than ever before. But a new, potentially game-changing ally is emerging in the quest to deepen our understanding of life’s complexities: quantum computing. Early signs suggest that quantum-enhanced AI could give biotech research a major shot in the arm—enabling new breakthroughs in drug discovery, genomics, and computational biology at speeds previously thought unattainable. By harnessing qubits instead of binary bits, quantum computing can explore vast solution spaces in parallel, promising to streamline processes that currently cost millions of pounds and untold hours of lab time. In this article, we’ll explore: How quantum computing differs from traditional computing. Why AI, particularly in biotechnology, stands to benefit from quantum’s speed and scale. Practical applications—from rational drug design to personalised medicine—that could be revolutionised. The emergence of quantum-biotech roles, including salary insights and skill requirements. Actionable strategies for professionals ready to ride the next wave of scientific innovation. Whether you’re a biotech professional looking to future-proof your career, a student investigating the next hot field, or simply curious about the intersection of cutting-edge tech and life sciences, read on. You’ll discover how quantum-enhanced AI is poised to reshape biotechnology and what you can do to be part of this transformation.

Biotech Jobs at Newly Funded UK Start-ups: Q3 2025 Investment Tracker

Biotechnology in the United Kingdom is experiencing a golden age. Once considered a niche sector, biotech has emerged as a cornerstone of innovation—transforming healthcare, agriculture, environmental management, and beyond. From gene therapy breakthroughs to novel drug delivery platforms, British biotech start-ups are leading the charge on the global stage, fuelled by a potent combination of academic excellence, government incentives, and a steady flow of venture capital. In this Q3 2025 Investment Tracker, we delve into the most exciting biotechnology start-ups in the UK that have secured funding over the past quarter. We’ll look at who they are, how they plan to use their new capital, and—crucially for job seekers—what roles they’re hiring for. Whether you’re a recent graduate searching for your first laboratory role or an industry veteran looking to lead cutting-edge research, this roundup will illuminate the opportunities awaiting you in the booming UK biotech scene.